Table 1 Comparison of variables between HIV/TB patients and HIV/non-TB patients by univariate analysis
Variables | HIV/TB patients (n = 288) | HIV/non-TB patients | Z/F | p | |||
|---|---|---|---|---|---|---|---|
Viral infection (n = 23) | Fungal infection (n = 163) | Bacterial infection (n = 124) | Total (n = 310) | ||||
Demographic | |||||||
 Age (years) | 43.73 ± 13.43 | 46.17 ± 8.98 | 45.55 ± 14.88 | 48.92 ± 14.04 | 46.94 ± 14.24 | 2.897 | 0.005 |
 Male (n, %) | 238(82.6%) | 18(78.0%) | 125 (76.7%) | 96 (77%) | 239 (77.1%) | 2.841 | 0.092 |
Laboratory | |||||||
 WBC (109 cells/L) | 6.11 ± 3.27 | 4.80 ± 1.77 | 5.55 ± 5.07 | 6.23 ± 3.59 | 5.77 ± 4.35 | 1.074 | 0.283 |
 HGB (g/L) | 98.66 ± 20.76 | 117.78 ± 24.94 | 113.31 ± 21.94 | 110.67 ± 25.63 | 112.59 ± 23.70 | 7.618 | 0.000 |
 PLT (109 cells/L) | 201.16 ± 107.07 | 176.39 ± 110.85 | 218.09 ± 103.28 | 196.85 ± 90.75 | 206.50 ± 99.60 | 0.631 | 0.528 |
 ALB (g/L) | 32.54 ± 6.01 | 39.39 ± 5.20 | 34.83 ± 6.86 | 34.87 ± 6.46 | 35.19 ± 6.68 | 5.082 | 0.000 |
 CD4+ T-cell count (cells/μl) | 45 (1–591) | 86 (6–669) | 25 (1–504) | 54.5 (2–1252) | 37 (1–1252) | 1.324 | 0.186 |
  < 200 | 267(92.7%) | 16(69.6%) | 155(95.1%) | 103(83.1%) | 274(88.4%) | 3.233 | 0.094 |
  ≥ 200 | 21(7.3%) | 7(30.4%) | 8(4.9%) | 21(16.9%) | 36(11.6%) |  |  |
 HIV RNA (log10 copies/mL) | 5.00 ± 1.43 | 3.89 ± 1.71 | 4.99 ± 1.15 | 4.26 ± 1.75 | 4.62 ± 1.51 | 1.900 | 0.257 |
 ESR (mm/h) | 75.31 + 42.62 | 51.50 ± 40.81 | 70.39 ± 34.80 | 58.69 ± 39.93 | 48.42 + 42.86 | 7.681 | 0.000 |
 PCT (ng/ml) | 0.15(0–73.99) | 0.12(0–0.3) | 0.14 (0.01–18.62) | 0.12 (0.01–2.98) | 0.09(0–18.62) | 5.876 | 0.008 |
Symptoms | |||||||
 Weight loss (Kg) | 3(0–25) | 2(0–10) | 3(0–20) | 3(0–20) | 3(0–20) | 1.689 | 0.091 |
 Fever (n, %) | 225(78.1%) | 12 (52.2%) | 94 (57.7) | 74 (60%) | 180 (58.1%) | 27.487 | 0.000 |
 Highest body temperature (°C) | 38.79 ± 1.29 | 37.37 ± 0.95 | 37.89 ± 1.15 | 37.92 ± 1.12 | 37.86 ± 1.13 | 9.400 | 0.000 |
CT scan | |||||||
 Number of infected pulmonary lobes (n) | 5(0–5) | 2 (0–5) | 2 (0–5) | 3 (0–5) | 3 (0–5) | 8.665 | 0.000 |
 Opacities (n, %) | 250(86.8%) | 22 (95.7%) | 128 (78.5%) | 106 (85%) | 256 (82.6%) | 2.047 | 0.152 |
 Solid lesion (n, %) | 126(43.8%) | 6 (26.1%) | 43 (26%) | 57 (46%) | 106 (34.2%) | 5.742 | 0.017 |
 Pulmonary cavitation (n, %) | 36(12.5%) | 0 (0%) | 4 (2%) | 5 (4%) | 9 (2.9%) | 19.759 | 0.000 |
 Pleural effusion (n, %) | 150(52.1%) | 0 (0%) | 29 (18%) | 11 (9%) | 40 (12.9%) | 105.724 | 0.000 |
 Cervical lymphadenopathy (n, %) | 33(11.5%) | 1 (4.3%) | 5 (3%) | 4 (3%) | 10 (3.2%) | 15.162 | 0.000 |
 Axillary lymphadenopathy (n, %) | 11(3.8%) | 3 (13.0%) | 2 (1.2%) | 1 (0.8%) | 6 (1.9%) | 1.919 | 0.166 |
 Inguinal lymphadenopathy (n, %) | 10(3.5%) | 0 | 5 (3.1%) | 1 (0.8%) | 6 (1.9%) | 1.354 | 0.245 |
 Hilar and/or mediastinal lymphadenopathy (n, %) | 212(73.6%) | 1 (4.3%) | 47 (29%) | 44 (35%) | 92 (29.7%) | 115.3 | 0.000 |
 Pericardial effusion (n, %) | 37(12.8%) | 2 (8.6%) | 8 (5%) | 3 (2%) | 13 (4.2%) | 14.592 | 0.000 |
 Miliary nodules (n, %) | 76(26.4%) | 0 (0%) | 2 (1%) | 0 (0%) | 2 (0.6%) | 87.237 | 0.000 |